Otonomy to Participate in Piper Jaffray 30th Annual Healthcare Conference
November 15 2018 - 8:30AM
Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company
dedicated to the development of innovative therapeutics for
otology, today announced that David A. Weber, Ph.D., president and
chief executive officer, will participate in a fireside chat at the
30th Annual Piper Jaffray Healthcare Conference on Tuesday,
November 27, 2018 at 3:00 p.m. ET (12:00 p.m. PT) at the Lotte New
York Palace in New York City.
A live audio webcast of the fireside chat will be available
through the Events and Presentations page of the company's website
(www.otonomy.com).
About Otonomy
Otonomy is a biopharmaceutical company dedicated to the
development of innovative therapeutics for otology. The company
pioneered the application of drug delivery technology to the ear in
order to develop products that achieve sustained drug exposure from
a single local administration. This approach is covered by a broad
patent estate and is being utilized to develop a pipeline of
products addressing important unmet medical needs including
Ménière’s disease, hearing loss, and tinnitus. For additional
information please visit www.otonomy.com.
Contacts:
Media Inquiries Spectrum Leticia Diaz Vice President
202.587.2517 ldiaz@spectrumscience.com
Investor InquiriesWestwicke PartnersRobert H. UhlManaging
Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Sep 2023 to Sep 2024